Bibliometric Study About the Impact of Biosimilars Drugs
DOI:
https://doi.org/10.30827/ars.v58i3.6527Keywords:
Biological drugs, biosimilars drugs, economic impactAbstract
Objectives: A bibliometrics study is a type of statistical study on scientific data. With this tool we want to visualize different aspects of biosimilar drugs, their importance and the impact they generate in their environment.
Methods: Science Direct was utilized as a search engine, in addition to the scientific publications referenced in the bibliography as well as some websites concerning the subject.
Results: Almost all the indicators point to the great economic importance of biosimilar drugs, their novelty and their patient-coentered focus.
Conclusions: It is of great interest to know the future impact that these medicines will have and the repercussions they will bring, especially in the economic and health fields.
Downloads
References
Mingersa J, Leydesdorffb L. A review of theory and practice in scientometrics. Eur J Oper Res. 2015; 246(1):1-19.
Calvo B, Zúñiga L, Gómez P. Evaluación de la biosimilitud y comparabilidad de medicamentos biosimilares. Ars Pharm. 2013; 54(4):32-36.
Villamañán E, González D, Armada E, Ruano M, Álvarez-Sala R, Herrero A. Juego de patentes. Sobre medicamentos genéricos y biosimilares. The patents game. Generic and biosimilar drugs. Rev Calid Asist. 2016; 31(2):99-105.
Schimizzi G.F. Biosimilars from a practicing rheumatologist perspective: An overview. Autoimmun Rev. 2016; 15(9):911-916
Flyvbjerg H. Biomathematics. Mathematics of Biostructures and Biodynamics. Chem Phys Lipids. 2000; 106(2):191-192.
Romain O. Preud'homme D. Actualités pharmaceutiques. Arch Pediatr. 2007; 14(10):1274-1277.
Blog biosim. Asociación Española de biosimilares. [consultado el10/8/2017]. Disponible en: http://www.biosim.es/blog/
Girault D, Trouvin JH, Blachier-Poisson C, Gary F, Laloye D. Biosimilars: from Technical to Pharmacoeconomic Considerations. Ther. 2015; 70(1):47-55.
Downloads
Published
How to Cite
Issue
Section
License
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
